advisory boards

Italy's D3 Unites Pharmaceutical Industry, Academia for Public Health

A report in yesterday’s Pharma Letter illustrates how critical partnerships between the pharmaceutical industry and academia can be beneficial for patients, medical professionals and the pharmaceutical industry alike. The Italian Institute of Technology’s Drug Discovery and Development Unit (D3) “brings together scientists with experience in industry and academia to discover new drugs in pain, inflammation …

Italy's D3 Unites Pharmaceutical Industry, Academia for Public Health Read More »

Thought Leader Select begins key research and advisory services for seven global pharmaceutical companies

New press release out today, celebrating the tremendous efforts of our business development and research teams. FOR IMMEDIATE RELEASE March 9, 2009 (CHAPEL HILL, NC)  Thought Leader Select, a company dedicated to delivering solutions for better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, announces on-going research …

Thought Leader Select begins key research and advisory services for seven global pharmaceutical companies Read More »

The Numbers Don't Lie: The Global Impact of Thought Leader Select

Since 2005, Thought Leader Select has profiled over 4800 key opinion leaders and over 300 centers of excellence in the field of healthcare. The scope of our 72 completed research projects spans four continents—North America, Europe, Africa, and Asia. We have covered thought leaders in 12 therapeutic areas and over 33 disease states for the …

The Numbers Don't Lie: The Global Impact of Thought Leader Select Read More »